BOZZALLA CASSIONE, EMANUELE
 Distribuzione geografica
Continente #
NA - Nord America 916
AS - Asia 814
EU - Europa 605
SA - Sud America 123
AF - Africa 58
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.521
Nazione #
US - Stati Uniti d'America 881
SG - Singapore 248
CN - Cina 215
IT - Italia 140
IE - Irlanda 126
HK - Hong Kong 93
RU - Federazione Russa 86
BR - Brasile 85
DE - Germania 77
VN - Vietnam 69
BD - Bangladesh 50
ZA - Sudafrica 38
GB - Regno Unito 33
FR - Francia 31
IN - India 30
FI - Finlandia 25
AT - Austria 23
CA - Canada 20
AE - Emirati Arabi Uniti 18
JP - Giappone 13
IR - Iran 12
AR - Argentina 10
ES - Italia 10
EC - Ecuador 9
MX - Messico 9
IQ - Iraq 8
PL - Polonia 8
SA - Arabia Saudita 8
NL - Olanda 7
PK - Pakistan 7
SE - Svezia 7
CO - Colombia 6
CZ - Repubblica Ceca 5
EG - Egitto 5
MY - Malesia 5
PE - Perù 5
TR - Turchia 5
ID - Indonesia 4
MA - Marocco 4
MK - Macedonia 4
UZ - Uzbekistan 4
AU - Australia 3
KR - Corea 3
KZ - Kazakistan 3
LB - Libano 3
PH - Filippine 3
PY - Paraguay 3
RO - Romania 3
UA - Ucraina 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BE - Belgio 2
CL - Cile 2
DK - Danimarca 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
LK - Sri Lanka 2
LT - Lituania 2
NP - Nepal 2
OM - Oman 2
RS - Serbia 2
SN - Senegal 2
TN - Tunisia 2
VE - Venezuela 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
KW - Kuwait 1
NO - Norvegia 1
PT - Portogallo 1
RE - Reunion 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 2.521
Città #
San Jose 139
Singapore 127
Dublin 121
Dallas 92
Ashburn 90
Hong Kong 90
Chandler 77
Beijing 67
Los Angeles 40
Munich 39
Johannesburg 34
Milan 34
New York 34
Boardman 24
Ho Chi Minh City 23
Lauterbourg 23
Shanghai 21
Council Bluffs 18
Hanoi 18
Helsinki 18
Vienna 18
Dubai 17
Pavia 15
Princeton 15
Lawrence 14
Redondo Beach 14
Medford 12
Montreal 12
Tabriz 12
Seattle 11
Buffalo 10
Manchester 10
Moscow 10
Orem 10
São Paulo 10
Denver 9
Tokyo 9
Da Nang 8
Santa Clara 8
Wilmington 8
Atlanta 7
London 7
Turin 7
Turku 7
Warsaw 7
Rome 6
San Francisco 6
Genoa 5
Kuala Lumpur 5
Baghdad 4
Brooklyn 4
Changsha 4
Chennai 4
Guangzhou 4
Hyderabad 4
Nuremberg 4
Phoenix 4
Quito 4
Riyadh 4
Sassari 4
Stockholm 4
The Dalles 4
Wuhan 4
Bollate 3
Boston 3
Cairo 3
Charlotte 3
Chicago 3
Falkenstein 3
Frankfurt am Main 3
Hangzhou 3
Houston 3
Lahore 3
Mexico City 3
Norwalk 3
Olomouc 3
Querétaro 3
Rio de Janeiro 3
Tashkent 3
Tianjin 3
Tétouan 3
Almaty 2
Amman 2
Bacau 2
Beirut 2
Belgrade 2
Brussels 2
Cali 2
Campinas 2
Cape Town 2
Chongqing 2
Colombo 2
Columbus 2
Curitiba 2
Dakar 2
Dehradun 2
Düsseldorf 2
Fairfield 2
Fulham 2
Grand Rapids 2
Totale 1.566
Nome #
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 132
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine 131
Cytomegalovirus colitis unmasking human immunodeficiency virus infection as a cause of IgA vasculitis 120
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 120
Pulmonary nocardiosis in a patient affected by anti-MDA5-positive amyopathic dermatomyositis under immunosuppressive therapy 112
Prediction of long-term drug-free outcomes in ACPA-positive and -negative rheumatoid arthritis by combined clinical and ultrasound assessment of residual disease: a 5-year prospective study 111
Impact of immunosuppressive treatment on the immunogenicity of mRNA Covid-19 vaccine in vulnerable patients with giant cell arteritis 110
Janus kinase inhibitors effectively improve pain across different disease activity states in rheumatoid arthritis 109
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 101
Safety of BNT162b2 mRNA COVID-19 vaccine in a cohort of elderly, immunocompromised patients with systemic vasculitis 96
Lumbar spondylolisthesis associated with systemic sclerosis-related spinal calcinosis: an unusual clinical case 95
No evidence of short-term impact of repeated BNT162b2 vaccination on rheumatoid arthritis homeostasis in drug-free remission 94
Telemedicine: a useful tool but not the holy grail. Response to: 'Telemedicine will not keep us apart in the COVID-19 pandemic' by Perniola et al 94
Established rheumatoid arthritis. The pathogenic aspects. 93
Insights Into the Concept of Rheumatoid Arthritis Flare 92
Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina et al 89
Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners 89
High serum levels of CXCL13 predict lower response to csDMARDs in both ACPA-positive and ACPA-negative early rheumatoid arthritis 82
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 82
Synovial and serum B-cell signature of autoantibody-negative rheumatoid arthritis versus autoantibody-positive rheumatoid arthritis and psoriatic arthritis 80
Prediction of long-term drug-free outcomes in ACPA-positive and ACPA-negative rheumatoid arthritis by combined clinical and ultrasound assessment of residual disease: a 5-year prospective study 80
Timely escalation to second-line therapies after failure of methotrexate in patients with early rheumatoid arthritis does not reduce the risk of becoming difficult-to-treat 79
Methotrexate and rheumatoid arthritis associated interstitial lung disease 79
Response to: 'Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic' by Santos-Moreno et al 74
Tender joints in early autoantibody-negative rheumatoid arthritis: Should they be included in the scoring of joint involvement of the 2010 ACR/EULAR classification criteria? 69
Seronegative rheumatoid arthritis: one year in review 2023 65
IgG4-related disease 55
Janus kinase inhibitors effectively improve pain across different disease activity states in rheumatoid arthritis 43
null 18
Totale 2.594
Categoria #
all - tutte 10.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.442


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202281 2 0 0 0 9 1 1 5 3 2 14 44
2022/2023297 30 26 4 14 20 29 1 23 132 0 11 7
2023/2024204 15 61 6 12 10 41 16 17 5 6 3 12
2024/2025586 16 25 2 3 10 30 57 26 175 42 73 127
2025/20261.396 102 71 114 114 165 76 219 97 132 100 96 110
Totale 2.594